胆囊癌规范化诊治专家共识(2016)

中国抗癌协会

doi:10.3969/j.issn.1001-5256.2017.04.002

胆囊癌规范化诊治专家共识(2016)

DOI: 10.3969/j.issn.1001-5256.2017.04.002

中国抗癌协会

详细信息

中图分类号: R735.8
计量
- 文章访问数: 278
- HTML全文浏览量: 19
- PDF下载量: 1549
- 被引次数: 0
出版历程
- 出版日期: 2017-04-20

Guideline for the diagnosis and therapy of gallbladder carcinoma（2016）

Chinese Anti-Cancer Association

摘要

摘要:
<正>胆囊癌是临床常见的胆道系统恶性肿瘤。由于其高度恶性、极易发生淋巴转移及远隔器官转移等临床生物学特性,患者就医时往往因肿瘤分期较晚失去手术机会,而放疗、化疗等传统治疗手段亦未能在晚期胆囊癌的治疗中体现出显著的优势,故其患者总体预后仍极不乐观。此外,近年来对于慢性结石性胆囊炎等胆囊癌前病变的临床处理,仍有诸多争议和分歧,导致基层医疗单位对相关疾病诊疗原则的认识存在困难。鉴于此,中国抗癌协会胆道肿瘤专业委员会
- 胆囊肿瘤 /
- 诊断 /
- 治疗 /
- 诊疗准则
- gallbladder neoplasms /
- diagnosis /
- therapy /
- practice guideline

HTML全文

参考文献(83)

[1]WANG JH, JIANG XQ.Advances in epidemiology of primary gallbladder carcinoma[J/CD].Chin Arch General Surg:Electronic Edition, 2010, 4 (3) :271-273. (in Chinese) 王敬晗, 姜小清.原发性胆囊癌流行病学研究进展[J/CD].中华普通外科学文献:电子版, 2010, 4 (3) :271-273.

[2]FERLAY J, SHIN HR, BRAY F, et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer, 2010, 127 (12) :2893-2917.

[3]CUNNINGHAM SC, ALEXANDER HR.Porcelain gallbladder and cancer:ethnicity explains a discrepant literature?[J].Am J Med, 2007, 120 (4) :e17-e18.

[4]STINTON LM, SHAFFER EA.Epidemiology of gallbladder disease:cholelithiasis and cancer[J].Gut Liver, 2012, 6 (2) :1721-1787.

[5]HUNDAL R, SHAFFER EA.Gallbladder cancer:epidemiology and outcome[J].Clin Epidemiol, 2014, 6:99-109.

[6]SHEN HX, LI ZY, GENG ZM, et al.A clinical analysis of 2379patients with gallbladder carcinoma in 17 hospitals in five provinces of Northwest China[J].Chin J Surg, 2015, 53 (10) :747-751. (in Chinese) 慎浩鑫, 李昭宇, 耿智敏, 等.西北五省17家医院2379例胆囊癌临床分析[J].中华外科杂志, 2015, 53 (10) :747-751.

[7]AUNE D, NORAT T, VATTEN LJ.Body mass index, abdominal fatness and the risk of gallbladder disease[J].Eur J Epidemiol, 2015, 30 (9) :1009-1019.

[8]HU Z, CHEN LF, CHEN WS.Meta-analysis on the coRRelation between metabolic syndrome and hepatobiliary malignancy[J].Modern Instruments Med Treat, 2016, 22 (2) :1-4. (in Chinese) 胡珍, 陈兰芳, 陈文生.代谢综合征与肝胆恶性肿瘤相关性的Meta分析[J].现代仪器与医疗, 2016, 22 (2) :1-4.

[9]AUNE D, VATTEN LJ, BOFFETTA P.Tobacco smoking and the risk of gallbladder disease[J].Eur J Epidemiol, 2016, 31 (7) :643-653.

[10]YU JY, CUI QC.World Health Organiration classification of tumors:patholy&genetics:tumors of the digestive system[M].1st edition, Beijing:Medical Publishing House, 2006:246-262.虞积耀, 崔全才.世界卫生组织肿瘤分类及诊断标准系列:消化系统肿瘤病理学和遗传学[M].第1版, 北京:人民卫生出版社, 2006:246-262.

[11]ZHAO B, SHI JS, LI GC, et al.Analysis of the 1898 histologic type of primary carcinoma[J].China J Modern Med, 2000, 10 (10) :17-18. (in Chinese) 赵波, 石景森, 李国才, 等.原发性胆囊癌1898例病理类型的分析[J].中国现代医学杂志, 2000, 10 (10) :17-18.

[12]CHEN YL, HUANG ZQ, ZHOU NX, et al.Clinical analysis of squamous cell carcinoma and adenosquamous carcinoma of gallbladder in 12 cases[J].J Dig Surg, 2006, 5 (6) :414-416. (in Chinese) 陈永亮, 黄志强, 周宁新, 等.胆囊鳞癌和腺鳞癌12例临床分析[J].消化外科, 2006, 5 (6) :414-416.

[13]ZHOU YD, LI Q, ZHANG C, et al.Clinicopathological features of 11patients with adenosquamous carcinoma of the gallbladder[J].Chin J Hepatobiliary Surg, 2014, 20 (12) :889-891. (in Chinese) 周远达, 李强, 张倜, 等.胆囊腺鳞癌11例患者临床病理特征[J].中华肝胆外科杂志, 2014, 20 (12) :889-891.

[14]PRADEEP R, KAUSHIK SP, SIKORA SS, et al.Predictors of survival in patients with carcinoma of the gallbladder[J].Cancer, 1995, 76 (7) :1145-1149.

[15]SHIBA H, MISAWA T, FUJIWARA Y, et al.Glasgow prognostic score predicts outcome after surgical resection of gallbladder cancer[J].World J Surg, 2015, 39 (3) :753-738.

[16]DONG NN, ZHANG C, LI Q, et al.Analysis of treatment and prognosis of primary gallbladder cancer[J].Chin J Dig Surg, 2012, 11 (3) :267-270. (in Chinese) 董娜娜, 张倜, 李强, 等.原发性胆囊癌的治疗策略和预后分析[J].中华消化外科杂志, 2012, 11 (3) :267-270.

[17]QIU YH, LIU C, JIANG XQ, et al.Long-term results of surgical treatment in 181 cases of advanced stage gallbladder carcinoma[J].Chin J Hepatobiliary Surg, 2010, 16 (9) :655-658. (in Chinese) 邱应和, 刘辰, 姜小清, 等.181例进展期胆囊癌外科治疗的预后分析[J].中华肝胆外科杂志, 2010, 16 (9) :655-658.

[18]STROM BL, SOLOWAY RD, RIOS-DALENZ J, et al.Biochemical epidemiology of gallbladder cancer[J].Hepatology, 1996, 23 (6) :1402-1411.

[19]CHAUBE A, TEWARI M, SINGH U, et al.CA 125:a potential tumor marker for gallbladder cancer[J].J Surg Oncol, 2006, 93 (8) :665-669.

[20]WANG YF, FENG FL, JIANG XQ, et al.Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer[J].World J Gastroenterol, 2014, 20 (14) :4085-4092.

[21]CHEN YL, HUANG ZQ, ZHOU NX, et al.Clinical analysis of 110patients with primary gallbladder carcinoma[J].Chin J Oncol, 2007, 29 (9) :704-706. (in Chinese) 陈永亮, 黄志强, 周宁新, 等.原发性胆囊癌110例临床分析[J].中华肿瘤杂志, 2007, 29 (9) :704-706.

[22]PILGRIM CH, GROESCHL RT, PAPPAS SG, et al.An often overlooked diagnosis:imaging features of gallbladder cancer[J].J Am Coll Surg, 2013, 216 (2) :333-339.

[23]ZEVALLOS MC, RUIZ LOPEZ MJ, GONZALEZ VALVERDE FM, et al.Ultrasound findings associated to gallbladder carcinoma[J].Cir Esp, 2014, 92 (5) :348-355.

[24]SONG ER, CHUNG WS, JANG HY, et al.CT differentiation of 1-2-cm gallbladder polyps:benign vs malignant[J].Abdom Imaging, 2014, 39 (2) :334-341.

[25]TAN CH, LIM KS.MRI of gallbladder cancer[J].Diagn Interv Radiol, 2013, 19 (4) :312-319.

[26]HU B, ZHOU DY, WU P, et al.The relationship between anomalous junction of pancreaticobiliary duct and gallbladder carcinoma in Chinese patients[J].Chin J Dig Endosc, 2004, 21 (4) :225-228. (in Chinese) 胡冰, 周岱云, 吴萍, 等.先天性胆胰管合流异常与胆囊癌的关联[J].中华消化内镜杂志, 2004, 21 (4) :225-228.

[27]RAMOS-FONT C, GMEZ-RIO M, RODRGUEZ-FERN-NDEZ A, et al.Ability of FDG-PET/CT in the detection of gallbladder cancer[J].J Surg Oncol, 2014, 109 (3) :218-224.

[28]KE QH, HE ZL, DUAN X, et al.Chronic cholecystitis with hilar bile duct stricture mimicking gallbladder carcinoma on positron emission tomography:a case report[J].Mol Clin Oncol, 2013, 1 (3) :517-520.

[29]MANOHAR K, MITTAL BR, BHATTACHARYA A, et al.Intense FDG activity in a case of xanthogranulomatous cholecystitis without elevated fluorothymidine activity[J].Clin Nucl Med, 2013, 38 (4) :e205-e206.

[30]OUYANG J, TANG D, LIANG LJ, et al.Analysis of the clinicopathological features and prognosis of incidental gallbladder cancer[J/CD].Chin J Clinicians:Electronic Edition, 2011, 5 (12) :3441-3444. (in Chinese) 欧阳杰, 汤地, 梁力建, 等.意外胆囊癌的临床病理特点与预后分析[J/CD].中华临床医师杂志:电子版, 2011, 5 (12) :3441-3444.

[31]JIANG XQ, QIU YH.Diagnosis and treatment of unsuspected gallbladder carcinoma[J].Chin J Dig Surg, 2011, 10 (2) :91-92. (in Chinese) 姜小清, 邱应和.意外胆囊癌的诊断与治疗[J].中华消化外科杂志, 2011, 10 (2) :91-92.

[32]FENG FL, LIU C, JIANG XQ, et al.Role of radical resection in patients with gallbladder carcinoma and jaundice[J].Chin Med J, 2012, 125 (5) :752-756.

[33]HU B, ZHOU DY, GONG B, et al.Endoscopic palliative treatment for malignant obstructivejaundice:a report of 929 cases[J].Chinese-Geman J Clin Oncol Arch, 2002, 1 (1) :32-35.

[34] SOBIN LH, GOSPODAROWICZ MK.TNM classification of malignant tumors[M].7th ed.Tianjin:Tianjin Science&Technology Translation&Publishing Corp, 2009:119-122. (in Chinese) SOBIN LH, GOSPODAROWICZ MK.恶性肿瘤TNM分期[M].7th ed.天津:天津科技翻译出版公司, 2009:119-122.

[35]LI B, ZHANG BH, JIANG XQ, et al.An interpretation of modification of the TNM staging system for biliary tumors and standardization of surgical treatment of biliary tumors[J].Chin J Gen Surg, 2012, 27 (3) :255-257. (in Chinese) 李斌, 张柏和, 姜小清, 等.解读胆道肿瘤TNM分期变化, 规范胆道肿瘤的外科治疗[J].中华普通外科杂志, 2012, 27 (3) :255-257.

[36]YU Y, JIANG XQ.Surgical treatment by stages for gallbladder carcinoma[J/CD].Chin J Hepatic Surg:Electronic Edition, 2012, 1 (3) :151-156. (in Chinese) 于勇, 姜小清.胆囊癌的外科分期治疗[J/CD].中华肝脏外科手术学电子杂志, 2012, 1 (3) :151-156.

[37]ZHANG R, PENG CH, LI HW, et al.Aggressive surgical treatment for107 cases of gallbladder carcinoma[J].Chin J Clin Oncol, 2009, 36 (4) :195-198. (in Chinese) 张瑞, 彭承宏, 李宏为, 等.107例原发性胆囊癌的外科治疗分析[J].中国肿瘤临床, 2009, 36 (4) :195-198.

[38]PENG CH, CHEN S.Surgical treatment for advanced gallbladder carcinoma[J].J Clin Surg, 2010, 18 (2) :78-79. (in Chinese) 彭承宏, 陈胜.进展期胆囊癌的外科治疗[J].临床外科杂志, 2010, 18 (2) :78-79.

[39]YOSHIMITSU K, HONDA H, KANEKO K, et al.Anatomy and clinical importance of cholecystic venous drainage:helical CT observations during injection of contrast medium into the cholecystic artery[J].AJR Am J Roentgenol, 1997, 169 (2) :505-510.

[40]YOSHIKAWA T, ARAIDA T, AZUMA T, et al.Bisubsegmental liver resection for gallbladder cancer[J].Hepatogastroenterology, 1998, 45 (19) :14-19.

[41]ZHOU JX, SUN XT, QIU YD, et al.The application of hepatectomy in gallbladder cancer[J].J Hepatobiliary Surg, 2006, 14 (1) :13-15. (in Chinese) 周建新, 孙喜太, 仇毓东, 等.肝切除在胆囊癌治疗中的应用[J].肝胆外科杂志, 2006, 14 (1) :13-15.

[42]PENG SY, HONG DF.Selection of surgical procedures for gallbladder cancer[J].Chin J Dig Surg, 2011, 10 (2) :87-90. (in Chinese) 彭淑牖, 洪德飞.胆囊癌手术方式的合理选择[J].中华消化外科杂志, 2011, 10 (2) :87-90.

[43]HONG DF, PENG SY.Evidence based of radical surgery for gallbladder carcinoma and its evaluation[J].J Surg Concepts Pract, 2011, 16 (4) :336-339. (in Chinese) 洪德飞, 彭淑牖.胆囊癌合理根治术的决策依据和疗效评价[J].外科理论与实践, 2011, 16 (4) :336-339.

[44]BIE P, HE Y.Standardized radical resection of gallbladder carcinoma[J].Chin J Pract Surg, 2011, 31 (3) :255-257. (in Chinese) 别平, 何宇.规范的胆囊癌根治术[J].中国实用外科杂志, 2011, 31 (3) :255-257.

[45]SHINDOH J, de ARETXABALA X, ALOIA TA, et al.Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer:an international multicenter study[J].Ann Surg, 2015, 261 (4) :733-739.

[46]LEE H, CHOI DW, PARK JY, et al.Surgical strategy for T2 gallbladder cancer according to tumor location[J].Ann Surg Oncol, 2015, 22 (8) :2779-2786.

[47]LIU YB, LIU FB, PENG SY.Extent, procedure selection, and evaluation of extended radical resection of gallbladder carcinoma[J].J Pract Oncol, 2005, 20 (1) :14-16. (in Chinese) 刘颖斌, 刘付宝, 彭淑牖.胆囊癌扩大根治术范围、术式选择及评价[J].实用肿瘤杂志, 2005, 20 (1) :14-16.

[48]LI SQ, LIANG LJ.Extended radical resection of gallbladder carcinoma and prevention of its complications[J].J Pract Oncol, 2005, 20 (1) :12-13. (in Chinese) 李绍强, 梁力建.胆囊癌扩大根治术及其并发症的预防[J].实用肿瘤杂志, 2005, 20 (1) :12-13.

[49]KE NW, ZENG Y.Therapeutic effets of different surgical procedures for the treatment of gallbladder cancer[J].Chin J Dig Surg, 2011, 10 (2) :96-99. (in Chinese) 柯能文, 曾勇.胆囊癌不同手术方式的疗效分析[J].中华消化外科杂志, 2011, 10 (2) :96-99.

[50]DUAN WH, ZHOU NX, LIU QD, et al.Expanded radical resection for gallbladder cancer at different portions[J].Chin J Gen Surg, 2011, 26 (9) :739-742. (in Chinese) 段伟宏, 周宁新, 刘全达, 等.不同部位胆囊癌扩大根治术的价值[J].中华普通外科杂志, 2011, 26 (9) :739-742.

[51]CHEN YL, HUANG XQ, ZHOU NX, et al.Effect of the differences in clinical classification and operational method of gallbladder carcinoma on the prognosis after resection[J].Clin Med Chin, 2009, 25 (2) :146-147. (in Chinese) 陈永亮, 黄晓强, 周宁新, 等.不同临床分期及手术方式对胆囊癌切除术患者预后的影响[J].中国综合临床杂志, 2009, 25 (2) :146-147.

[52]MIYAZAKI M, OHTSUKA M, MIYAKAWA S, et al.Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery:3 (rd) English edition[J].J Hepatobiliary Pancreat Sci, 2015, 22 (3) :181-196.

[53]ITO M, MISHIMA Y, SATO T.An anatomical study of the lymphatic drainage of the gallbladder[J].Surg Radiol Anat, 1991, 13 (2) :89-104.

[54]MENG XK, PENG SY, PENG CH, et al.The clinicopathological analysis of lymph node metastasis of gallbladder carcinoma[J].Chin J Gen Surg, 2001, 16 (10) :605-606. (in Chinese) 孟兴凯, 彭淑牖, 彭承宏, 等.胆囊癌淋巴结转移的临床病理学分析[J].中华普通外科杂志, 2001, 16 (10) :605-606.

[55]BIRNBAUM DJ, VIGANL, RUSSOLILLO N, et al.Lymph node metastases in patients undergoing surgery for a gallbladder cancer.extension of the lymph node dissection and prognostic value of the lymph node ratio[J].Ann Surg Oncol, 2015, 22 (3) :811-818.

[56]AMINI N, KIM Y, WILSON A, et al.Prognostic implications of lymph node status for patients with gallbladder cancer:a multi-institutional study[J].Ann Surg Oncol, 2016, 23 (9) :3016-3023.

[57]PICCOLO G, di VITA M, CAVALLARO A, et al.Lymph node evaluation in gallbladder cancer:which role in the prognostic and therapeutic aspects.Update of the literature[J].Eur Rev Med Pharmacol Sci, 2014, 18 (2 Suppl) :47-53.

[58]ZHANG BH, JIANG XQ, LUO XJ, et al.Selection and evaluation on liver transplantation in end-stage of disease of biliary system[J].Oncol Progr, 2005, 3 (5) :423-425. (in Chinese) 张柏和, 姜小清, 罗祥基, 等.胆系疾病终末期行肝移植的适应证选择及评价[J].癌症进展, 2005, 3 (5) :423-425.

[59]STEIN A, ARNOLD D, BRIDGEWATER J, et al.Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) -a randomized, multidisciplinary, multinational phaseⅢtrial[J].BMC Cancer, 2015, 15:564.

[60]MORIZANE C, OKUSAKA T, MIZUSAWA J, et al.Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer:a Japan Clinical Oncology Group trial[J].Cancer Sci, 2013, 104 (9) :1211-1216.

[61]SHAN BJ, HU B.Clinical observation of gemcitabine combined with tegafur in the treatment of advanced gall bladder cancer[J].J Hepatobiliary Surg, 2015, 23 (5) :336-338. (in Chinese) 单本杰, 胡冰.吉西他滨联合替吉奥方案治疗晚期胆囊癌临床观察[J].肝胆外科杂志, 2015, 23 (5) :336-338.

[62]MALKA D, CERVERA P, FOULON S, et al.Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO) :a randomised, open-label, non-comparative phase 2trial[J].Lancet Oncol, 2014, 15 (8) :819-828.

[63]LEE J, PARK SH, CHANG HM, et al.Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer:a multicentre, open-label, randomised, phase 3 study[J].Lancet Oncol, 2012, 13 (2) :181-188.

[64]LI M, ZHANG Z, LIU Y, et al.Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the Erb B pathway[J].Nat Genet, 2014, 46 (8) :872-876.

[65]GU X, LI B, JIANG M, et al.RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma[J].Oncotarget, 2015, 6 (24) :20661-20671.

[66]YANG J, SUN YJ, MENG Y, et al.Efficacy of radiotherapy of patients with middle-advanced gallbladder carcinoma and analysis of influential factor of prognosis[J].J Clin Res, 2012, 29 (8) :1441-1444. (in Chinese) 杨倞, 孙永健, 孟岩, 等.中晚期胆囊癌放疗疗效及预后影响因素分析[J].医学临床研究, 2012, 29 (8) :1441-1444.

[67] YANG J, FENG FL, MENG Y, et al.Analysis of the efficacy of postoperative radiotherapy in gallbladder cancer[J].Chin J Oncol, 2013, 35 (7) :534-539. (in Chinese) 杨倞, 冯飞灵, 孟岩, 等.胆囊癌术后辅助性放疗的疗效分析[J].中华肿瘤杂志, 2013, 35 (7) :534-539.

[68]LU WQ, WANG BS, LIU HB, et al.Diagnosis and treatment of Nevin Stage V gallbladder cancer[J].Chin J Pract Surg, 2001, 21 (2) :107-108. (in Chinese) 陆维祺, 王炳生, 刘厚宝, 等.Nevin V期胆囊癌的诊断和治疗[J].中国实用外科杂志, 2001, 21 (2) :107-108.

[69]HU B.Current status and perspectives of endoscopic palliative therapy for advanced pancreaticobiliary tumors[J].Chin J Min Inv Surg, 2007, 7 (8) :714-716. (in Chinese) 胡冰.内镜姑息性治疗中晚期胆胰肿瘤的现状与展望[J].中国微创外科杂志, 2007, 7 (8) :714-716.

[70]MU HC, CUI SZ.Clinical application of continuous hyperthermic peritoneal perfusion chemotherapy in hepatobiliary and pancreatic malignant tumors[J/CD].J Digest Oncol:Electronic Version, 2012, 4 (4) :223-227. (in Chinese) 牟洪超, 崔书中.持续循环腹腔热灌注化疗治疗肝胆胰恶性肿瘤的临床应用[J/CD].消化肿瘤杂志:电子版, 2012, 4 (4) :223-227.

[71]TIAN H, CHEN L, PENG SY, et al.Surgical treatments of preoperative unsuspected gallbladder carcinoma[J].Chin J Surg, 2005, 43 (13) :836-838. (in Chinese) 田华, 陈力, 彭淑牖, 等.意外胆囊恶性肿瘤的外科治疗[J].中华外科杂志, 2005, 43 (13) :836-838.

[72]SUN JF, ZHAO HW, WANG TH, et al.Meta-analysis of the efficacy of radical-resection and simple-cholecystectomy for gallbladder carcinoma[J].Chin J Surg Oncol, 2013, 5 (1) :33-36. (in Chinese) 孙静锋, 赵何伟, 王太洪, 等.根治性切除及单纯胆囊切除对Ⅱ期胆囊癌疗效的Meta分析[J].中国肿瘤外科杂志, 2013, 5 (1) :33-36.

[73]ABRAMSON MA, PANDHARIPANDE P, RUAN D, et al.Radical resection for T1b gallbladder cancer:a decision analysis[J].HPB (Oxford) , 2009, 11 (8) :656-663.

[74]HARI DM, HOWARD JH, LEUNG AM, et al.A 21-year analysis of stage I gallbladder carcinoma:is cholecystectomy alone adequate?[J].HPB (Oxford) , 2013, 15 (1) :40-48.

[75]FU WY, PENG CH, LI HW, et al.The survival analysis of unexpected gallbladder carcinoma by laparoscopic cholecystectomy[J/CD].Chin J Laparoscopic Surgery:Electronic Edition, 2014, 7 (2) :77-80. (in Chinese) 傅文禕, 彭承宏, 李宏为, 等.腹腔镜胆囊切除术发现意外胆囊癌患者的生存分析[J/CD].中华腔镜外科杂志:电子版, 2014, 7 (2) :77-80.

[76]LIU WY, LIU HB, XU ZP, et al.Misdiagnosis reasons carcinoma of gallbladder on (report of 19 cases) [J].J Hepatobiliary Surg, 2000, 8 (5) :339-340. (in Chinese) 刘维燕, 刘厚宝, 徐子平, 等.胆囊癌误诊原因分析 (附19例报告) [J].肝胆外科杂志, 2000, 8 (5) :339-340.

[77]GARG PK, PANDEY D, SHARMA J.The surgical management of gallbladder cancer[J].Expert Rev Gastroenterol Hepatol, 2015, 9 (2) :155-166.

[78]ZOU YF, FENG ZQ, ZHANG HY.Meta-analysis of recurrence rate and its risk factor after cholecystolithotomy[J].Mil Med J Southeast China, 2016, 18 (3) :230-239. (in Chinese) 邹玉锋, 冯志强, 张洪义.保胆取石术后结石复发危险因素的Meta分析[J].东南国防医药, 2016, 18 (3) :230-239.

[79]TEWARI M.Contribution of silent gallstones in gallbladder cancer[J].J Surg Oncol, 2006, 93 (8) :629-632.

[80]MISRA S, CHATURVEDI A, MISRA NC, et al.Carcinoma of the gallbladder[J].Lancet Oncol, 2003, 4:167-176.

[81]TREVINO F, CARTER O.Gallstone size and the risk of gallbladder cancer[J].JAMA, 1984, 250 (23) :3080-3081.

[82]LOWENFELS AB, WALKER AM, ALTHAUS DP, et al.Gallstone growth, size, and risk of gallbladder cancer:an interracial study[J].Int J Epidemiol, 1989, 18 (1) :50-54.

[83]HOUSSET C, CHRTIEN Y, DEBRAY D, et al.Functions of the gallbladder[J].Compr Physiol, 2016, 6 (3) :1549-1577.

施引文献

资源附件(0)

访问统计